New Insight into the Role of Obstructive Sleep Apnea in Cardiometabolic Diseases

Open access


Humans spend almost one third of their life sleeping, thus sleep deprivation or poor sleep quality will have consequences upon the quality of life. Obstructive sleep apnea (OSA) is the most common sleep disorder that represents a respiratory cessation for at least ten seconds, which appears repeatable during sleep and it is accompanied by decreased oxygen saturation. The diagnosis of OSA is possible by filling in the STOP, STOP BANG, BERLIN questionnaires and performing the polysomnography, an accessible and more accurate method but yet very expensive. The prevalence of OSA is continuously increasing, but because of the nonspecific symptoms, the percentage of un-diagnosed cases is further increased. Data from 11 epidemiological studies published between 1993 and 2014 indicated an OSA prevalence of 22% in men and 17% in women. It has been suggested that there is a bidirectional causal relationship between OSA and obesity, and numerous studies have shown association of OSA with insulin resistance, diabetes mellitus, diabetic micro- and macrovascular complications and atrial fibrillation.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. De Vega Sánchez B Juarros Martinez SA Del Olmo Chiches M Disdier Vicente C González Sarmiento E. Obstructive sleep apnoea type 2 diabetes and cardiovascular risk factors. Eur J Intern Med 39: E16-E17 2017.

  • 2. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Ekoé JM Punthakee Z et al. Screening for type 1 and type 2 diabetes. Can J Diabetes 37 [Suppl. 1]: S12-S15 2013.

  • 3. Basoglu OK Tasbakan MS. Gender differences in clinical and polysomnographic features of obstructive sleep apnea: a clinical study of 2827 patients. Sleep Breath doi: 10.1007/s11325-017-1482-9 2017. [Epub ahead of print]

  • 4. Westlake K Polak J. Screening for obstructive sleep apnea in type 2 diabetes patients – questionnaires are not good enough. Front Endocrinol (Lausanne) 7: 124 2016.

  • 5. Myers KA Mrkobrada M Simel DL. Does this patient have obstructive sleep apnea?: The Rational Clinical Examination systematic review. JAMA 310: 731-741 2013.

  • 6. Westlake K Plihalova A Pretl M Lattova Z Polak J. Screening for obstructive sleep apnea syndrome in patients with type 2 diabetes mellitus: a prospective study on sensitivity of Berlin and STOP-Bang questionnaires. Sleep Med 26: 71-76 2016.

  • 7. Jonas DE Amick HR Feltner C et al. Screening for obstructive sleep apnea in adults: an evidence review for the U.S. Preventive Services Task Force. Evidence synthesis number 146. Rockville (MD): Agency for Healthcare Research and Quality (US). Report No: 14-05216-EF-1 2017. Accessed on 20th February 2017 at

  • 8. Rasche K Keller T Hader C Leidag M Prinz C. Impact of obstructive sleep apnoea on type 2 diabetes and vice versa. European Endocrinology 9: 107-109 2013.

  • 9. Franklin KA Lindberg E. Obstructive sleep apnea is a common disorder in the population - a review on the epidemiology of sleep apnea. J Thorac Dis 7: 1311-1322 2015.

  • 10. Adams RJ Appleton SL Vakulin A et al. Association of kidney disease with obstructive sleep apnea in a population study of men. Sleep 2016 pii: sp-00240-16 2016. [Epub ahead of print]

  • 11. Zhang P Zhang R Zhao F et al. The prevalence and characteristics of obstructive sleep apnea in hospitalized patients with type 2 diabetes in China. J Sleep Res 25: 39-46 2016.

  • 12. Amin A Ali A Altaf QA et al. Prevalence and associations of obstructive sleep apnea in South Asians and white Europeans with type 2 diabetes: A cross-sectional study. J Clin Sleep Med 13: 583-589 2017.

  • 13. US Preventive Services Task Force Bibbins-Domingo K Grossman DC et al. Screening for obstructive sleep apnea in adults: US preventive services task force recommendation statement. JAMA 317: 407-414 2017.

  • 14. Mokhlesi B Hagen EW Finn LA Hla KM Carter JR Peppard PE. Obstructive sleep apnoea during REM sleep and incident non-dipping of nocturnal blood pressure: a longitudinal analysis of the Wisconsin Sleep Cohort. Thorax 70: 1062-1069 2015.

  • 15. World Health Organization. Obesity and overweight. Fact sheet – Updated June 2016. Accessed on 20th February 2017 at

  • 16. International Diabetes Federation. The IDF Consensus statement on sleep apnoea and type 2 diabetes. 2008. Accesed on 27th of January 2017 at

  • 17. Manin G Pons A Baltzinger P et al. Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications. Diabet Med 32: 90-96 2015.

  • 18. Farabi SS. Type 1 diabetes and sleep. Diabetes Spectr 29: 10-13 2016.

  • 19. Denic-Roberts H Costacou T Orchard TJ. Subjective sleep disturbances and glycemic control in adults with long-standing type 1 diabetes: The Pittsburgh’s Epidemiology of Diabetes Complications study. Diabetes Res Clin Pract 119: 1-12 2016.

  • 20. Reutrakul S Thakkinstian A Anothaisintawee T et al. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med 23: 26-45 2016.

  • 21. Tucker ME. Obstructive sleep apnea common in type 1 diabetes. 2015. Accessed on 31st January 2017 at

  • 22. Banghoej AM Nerild HH Kristensen PL et al. Obstructive sleep apneea is frequent in patients with type 1 diabetes. J Diabetes Complications 31: 156-161 2017.

  • 23. Nannapaneni S Ramar K Surani S. Effect of obstructive sleep apnea on type 2 diabetes mellitus: a comprehensive literature review. World J Diabetes 4: 238-244 2013.

  • 24. Plíhalová A Westlake K Polák J. Obstructive sleep apnoea and type 2 diabetes mellitus. Vnitr Lek 62 [Suppl. 4]: 79-84 2016.

  • 25. Cheung YY Tai BC Loo G et al. Screening for obstructive sleep apnea in the assessment of coronary risk. Am J Cardiol 119: 996-1002 2017.

  • 26. Botros N Concato J Mohsenin V Selim B Doctor K Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 122: 1122-1227 2009.

  • 27. Destors M Tamisier R Galerneau LM Lévy P Pepin JL. Pathophysiology of obstructive sleep apnea syndrome and its cardiometabolic consequences. Presse Med 46:395-403 2017

  • 28. Nagayoshi M Punjabi NM Selvin E et al. Obstructive sleep apnea and incident type 2 diabetes. Sleep Med 25: 156-161 2016.

  • 29. Handelsman Y Bloomgarden ZT Grunberger G et al. American Association of Clinical Endocrinologist and American College of Endocrinology - Clinical practice guidelines for developing a diabetes mellitus comprehensive care plan – 2015 – Executive Summary. Endocr Pract 21: 413-437 2015.

  • 30. Zhang R Zhang P Zhao F Han X Ji L. Association of diabetic microvascular complications and parameters of obstructive sleep apnea in patients with type 2 diabetes. Diabetes Technol Ther 18: 415-420 2016.

  • 31. Amra B Behjati M Penzel T Fietze I Schoebel C Sarrafzadegan N. Nocturnal heart rate variation in diabetic and non-diabetic patients with sleep apnea syndrome. Sleep Med 29: 57-60 2017.

  • 32. Baba A Zbiba W Bouayed E Korbi M Ghrairi H. Obstructive sleep apnea syndrome. Is it a risk factor for diabetic retinopathy? J Fr Ophtalmol 39: 139-142 2016.

  • 33. Song TJ Park JH Choi KH et al. Is obstructive sleep apnea associated with the presence of intracranial cerebral atherosclerosis? Sleep Breath 2017. doi: 10.1007/s11325-016-1450-9 2017. [Epub ahead of print]

  • 34. Song TJ Park JH Choi KH et al. Moderate-to-severe obstructive sleep apnea is associated with cerebral small vessel disease. Sleep Med 30: 36-42 2017.

  • 35. Hendrikx T Sundqvist M Sandström H et al. Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea. PLoS One 12: e0171575 2017.

Journal information
Impact Factor

CiteScore 2018: 0.19

SCImago Journal Rank (SJR) 2018: 0.128
Source Normalized Impact per Paper (SNIP) 2018: 0.229

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 252 119 4
PDF Downloads 127 66 1